- This event has passed.
EPILEPSY UPDATE CONFERENCE
November 4, 2016 - November 5, 2016
Brainworks Foundation Inc., Children’s Hospital Los Angeles and Epilepsy Foundation of Greater Los Angeles are pleased to announce the first annual Epilepsy Update Conference on November 4-6, 2016 at Disney’s Paradise Pier Hotel in Anaheim, CA. The conference is intended for neurologists, pediatricians, family practice physicians, ER physicians, advance practice providers, EEG technologists and nurses.
Learn about treatment options for epilepsy including medication, diet therapy, surgery and neuromodulation. Explore cutting edge information in this year’s “Hot Topics” section, including CBD oil, minimally invasive laser treatment and advances in the understanding and prevention of SUDEP. Participate in small break-out groups covering topics in the areas of EEG reading and seizure identification through the use of videos and interactive case studies.
- Improve the ability to diagnose seizures in young children, adolescents and adults.
- Recall the different treatment options available for the different seizure types.
- Become familiar with the new treatment options available for epilepsy.
- Help advise patients and families on rescue plans for emergency seizure treatment.
Registration is $175 for Physicians and $125 for Advance Practice Providers, EEG Technologists, Nurses and Residents.
Children’s Hospital Los Angeles is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. Children’s Hospital Los Angeles takes responsibility for the content, quality and scientific integrity of this CME activity. Children’s Hospital Los Angeles designates the Epilepsy Update Conference for a maximum of 10 hours of AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity. This credit may also be applied to the CMA Certification in Continuing Medical Education.
Children’s Hospital Los Angeles maintains control over the content of this CME activity, and will disclose to the audience any faculty or planner relationship with a pharmaceutical or industrial concern that might pose a potential, apparent or real conflict of interest with regard to its contribution to the program.